Category: Blogs

Dr. Kaiser Raja describes liver cirrhosis and how it can lead to liver failure and the need for a liver transplant

Dr. Kaiser Raja, Consultant in Liver Diseases, Transplant Hepatology, Gastroenterology and Advanced EndoscopyKings College Hospital London View this post on Instagram A post shared by Kaiser Raja (@kaiser.raja.md) Dr Kaiser Raja, Consultant in Liver Diseases, Transplant Hepatology, Gastroenterology & Advanced Endoscopy MD, describes liver cirrhosis and how it can lead to liver failure and the […]

Learn More
World Liver Day 19 April 2023

World Liver Day 19 April 2023

[vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_custom_heading text=”World Liver Day 19 April 2023 Measures for Healthy Liver” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes”][vc_empty_space height=”10px”][vc_column_text]World Liver Day (WLD) is a global healthcare event commemorated every year on the 19th of April with the intent to raise awareness about liver disease in the general public. Globally about 2 million people die every year due to liver diseases. Deaths […]

Learn More

A Story of Failure

We often talk of success stories. Let’s talk about a story where we failed. Dr. Chandra was an elderly gentleman settled in Dubai since past 40 years. He was a medical doctor and used to work at a Dubai Government Medical Clinic. He was a long-standing diabetic and slightly overweight. He used to manage his […]

Learn More
My New Year Surprise

My New Year Surprise

It was 17th November, and I got a What’s App message from a lady. It appeared she had a serious liver problem and had got my number from another doctor. The young lady was from Kenya, had come to Dubai for her first job at a hotel one year ago. About 6 months ago, she […]

Learn More
Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis

Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis

WASHINGTON — In patients with cirrhosis associated with non-alcoholic steatohepatitis (NASH), 1 year of treatment with the investigational oral thyromimetic agent resmetirom (MGL-3196) was safe and effective at lowering markers of both cardiovascular risk and NASH fibrosis, new research has found. Two cohorts comprising a total of 180 patients with well-compensated NASH cirrhosis enrolled in […]

Learn More
Have you tested for Hepatitis B

Have you tested for Hepatitis B

Hepatitis B is a virus that infects the liver. Most infected individuals have no symptoms till late in the course of the disease. Hepatitis B affects an estimated 250 million people worldwide and results in about 800000 deaths every year. The prevalence of hepatitis B infection is 1-5% worldwide. Areas of high prevalence include Southeast […]

Learn More
Whatsapp Now Get Clinic or Online Consultation